Doha: Sidra Medicine has signed a Memorandum of Understanding (MoU) with Builders VC MENA to enhance collaboration in the field of healthcare innovation. The agreement aims to support the development of new medical technologies and expand partnership opportunities between medical research ecosystems and healthcare-focused venture investments.

According to Qatar News Agency, Prof. Khalid Fakhro, Chief Research Officer at Sidra Medicine, expressed enthusiasm about the partnership as part of Sidra Medicine's Innovation Lab strategy. Over the past year, Sidra Medicine has established a living lab to foster biotech and health-tech innovations that address real-world healthcare challenges. Prof. Fakhro emphasized the potential for public-private partnerships and highlighted the value of Builders VC MENA's expertise and network in creating novel solutions for Qatar and beyond.

The MoU sets a framework for collaboration aimed at integrating venture-backed innovation with clinical applications. This includes introducing early-stage startups and advanced technologies into Qatar's healthcare system, as well as supporting and accelerating research-driven innovations from Sidra Medicine towards commercialization, investment, and global scaling.

The partnership, which is part of Sidra Medicine's Innovation Lab remit, and was further reinforced during the Web Summit Qatar 2026, will also focus on advancing solutions for improved patient outcomes, operational efficiency, and research excellence. It will facilitate scientific and commercial validation and support regional and international investment pathways.